1Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.Nature, 1998,391:806-811.
2Shirane D, Sugao K, Namiki S, et al. Enzymatic production of RNAi libraries from cDNAs. Nature Genet,2004 ,36 :190-196.
3Sato Y, Ajiki T, Inoue S,et al. Gene silencing. in rat-liver and limb grafts by rapid injection of small interference RNA. Transplantation,2005,79: 240 -243.
4Xia HB, Mao QW, Paulson HL, et al. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol,2002,20:1006-1010.
5Carette JE, Overmeer RM, Schagen FHE, et al. Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells. Cancer Res, 2004,64:2663 -2667.
6Xia HB, Mao QW, Eliason SL, et al. RNAi suppresses polyglutamine -induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med,2004,10:816-820.
7McCaffrey AP, Nakai H, Pandey K, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol, 2003,21: 639-644.
8Hamasaki K, Nakao K, Matsumoto K, et al. Short interfering RNAdirected inhibition of hepatitis B virus replication. FEBS Lett,2003,543:51-54.
9Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology. 2003,37:764-770.
10Lima RT, Martins LM, Guimaraes JE,et al. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Ther,2004,11:309-316.
二级参考文献16
1Kirkpatrick KL, Mokbel K. The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol, 2001,27:754-760.
2Mergny JL, Riou JF, Mailliet P, et al. Natural and pharmacological regulation of telomerase. Nucleic Acids Res,2002,30:839-865.
3Wang XW, Xiao JY, Zhao SP, et al. Expression of telomerase subumits and its relationship with telomerase activity in nasopharyngeal carcinoma. Natl Med J China,2001,81:553-556.王行炜,肖健云,赵素萍,等.鼻咽癌端粒酶各组分基
4Sui G, Soohoo C, Affar el B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci, 2002, 99:5515-5520.
5Perk NH, Guo W, Kim HR, et al. c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter. Int J Oncol, 2001, 19:755-761.
6Fujimoto K, Kyo S, Takakura M, et al. Identification and characterization of negative regulatory elements of the human telomerase catalytic aubunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. Nucleic Acids Res,200
7Oh ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1binding sites. J Virol, 2001, 75:5559-5566.
8Hou M, Wang X, Popov N, et al. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp Cell Res, 2002, 274:25-34.
9Kosciolek BA, Kalantidis K, Tabler M, et al. Inhibition of telomerase activity in human cancer cells by RNA interference. Mol Cancer Ther, 2003, 2:209-216.
10Kang SS, Kwon T, Kwon DY, et al. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. Biol Chem, 1999, 274:13085-13090.
